When multiple myeloma relapses

RESPOND with deeper response with Kyprolis®-based regimen (KRd)

KRd complete response

In the ASPIRE trial, KRd showed more than a 3 times higher rate of CR vs Rd.1

Adapted from Stewart et al.1

A KRd regimen results in higher QoL vs Rd

*Descriptive P value.

Please read the SmPC for full comprehensive safety information


  1. Stewart AK et al. N Engl J Med 2015;372:142–152.

Terms of Use

The information contained in this site is for European healthcare professionals only.